CIK: 0001622627 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 13, 2025
Total Value ($000): $292,563 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| DCTH | DELCATH SYS INC | 3,300,389 | $33,004 | 11.3% | $6.89 | +62.1% | COM NEW | 24661P807 |
| CYTK | CYTOKINETICS INC | 400,000 | $21,984 | 7.5% | $34.78 | +18.4% | COM NEW | 23282W605 |
| FENC | FENNEC PHARMACEUTICALS INC | 2,076,840 | $19,439 | 6.6% | $5.72 | +51.3% | COM | 31447P100 |
| VSTM | VERASTEM INC | 1,929,563 | $17,038 | 5.8% | $5.37 | +38.6% | COM NEW | 92337C203 |
| RZLT | REZOLUTE INC | 1,807,202 | $16,988 | 5.8% | $3.82 | +74.3% | COM NEW | 76200L309 |
| XERS | XERIS BIOPHARMA HOLDINGS INC | 1,795,766 | $14,618 | 5.0% | $1.86 | +256.8% | COM | 98422E103 |
| SVRA | SAVARA INC | 4,000,000 | $14,280 | 4.9% | $3.31 | -10.6% | COM | 805111101 |
| MDWD | MEDIWOUND LTD | 749,054 | $13,498 | 4.6% | $14.40 | +28.1% | SHS NEW | M68830112 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 600,000 | $12,948 | 4.4% | $16.51 | +9.2% | COM | 92790C104 |
| CGON | CG ONCOLOGY INC | 300,000 | $12,084 | 4.1% | $25.87 | +12.4% | COM | 156944100 |
| — | VERONA PHARMA PLC | 100,000 | $10,671 | 3.6% | $20.69 | — | SPONSORED ADS | 925050106 |
| IDYA | IDEAYA BIOSCIENCES INC | 350,000 | $9,524 | 3.3% | $21.31 | +13.5% | COM | 45166A102 |
| NSPR | INSPIREMD INC | 3,905,743 | $9,413 | 3.2% | $2.46 | -1.5% | COM | 45779A846 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 650,000 | $9,256 | 3.2% | $11.51 | 0.0% | COM NEW | 30233G209 |
| — | MIND MEDICINE MINDMED INC | 750,000 | $8,843 | 3.0% | $8.46 | — | COM NEW | 60255C885 |
| HELP | CYBIN INC | 1,500,000 | $8,835 | 3.0% | $8.75 | -19.0% | COM NEW | 23256X407 |
| GUTS | FRACTYL HEALTH INC | 5,000,000 | $7,950 | 2.7% | $1.30 | 0.0% | COM | 35168W103 |
| ATYR | ATYR PHARMA INC | 1,039,080 | $7,565 | 2.6% | $4.53 | 0.0% | COM NEW | 002120202 |
| QURE | UNIQURE NV | 125,000 | $7,296 | 2.5% | $18.16 | 0.0% | SHS | N90064101 |
| XFOR | X4 PHARMACEUTICALS INC | 1,544,607 | $5,283 | 1.8% | $2.58 | 0.0% | COM NEW | 98420X202 |
| OCUL | OCULAR THERAPEUTIX INC | 400,000 | $4,676 | 1.6% | $7.23 | +65.4% | COM | 67576A100 |
| — | ATYR PHARMA INC | 1,570,200 | $4,470 | 1.5% | — | — | Put | 002120952 |
| TLPH | TALPHERA INC | 4,385,757 | $3,917 | 1.3% | $0.60 | -2.9% | COM NEW | 00444T209 |
| PROF | PROFOUND MED CORP | 692,185 | $3,385 | 1.2% | $8.96 | -43.0% | COM NEW | 74319B502 |
| MYO | MYOMO INC | 3,790,788 | $3,381 | 1.2% | $3.11 | -53.2% | COM NEW | 62857J201 |
| PYPD | POLYPID LTD | 918,668 | $3,064 | 1.0% | $4.49 | -22.7% | COM | M8001Q126 |
| — | INVESCO QQQ TR | 250,000 | $1,557 | 0.5% | — | — | Put | 46090E953 |
| BFRI | BIOFRONTERA INC | 1,140,764 | $1,124 | 0.4% | $1.02 | -11.3% | COM NEW | 09077D209 |
| — | ASTRIA THERAPEUTICS INC | 1,542,520 | $1,113 | 0.4% | $0.72 | — | COM | 04635X102 |
| — | SPDR SERIES TRUST | 2,128,300 | $951 | 0.3% | — | — | Put | 78464A950 |
| TRVI | TREVI THERAPEUTICS INC | 100,000 | $915 | 0.3% | $2.31 | +224.8% | COM | 89532M101 |
| — | VERASTEM INC | 646,500 | $898 | 0.3% | — | — | Call | 92337C903 |
| KURA | KURA ONCOLOGY INC | 100,000 | $885 | 0.3% | $7.79 | -8.5% | COM | 50127T109 |
| — | SPDR S&P 500 ETF TR | 300,000 | $718 | 0.2% | — | — | Put | 78462F953 |
| — | REZOLUTE INC | 263,100 | $546 | 0.2% | — | — | Call | 76200L909 |
| — | IDEAYA BIOSCIENCES INC | 35,900 | $237 | 0.1% | — | — | Call | 45166A902 |
| — | REPLIMUNE GROUP INC | 511,400 | $183 | 0.1% | — | — | Call | 76029N906 |
| — | ISHARES TR | 200,000 | $20 | 0.0% | — | — | Put | 464287955 |
| — | SCHOLAR ROCK HLDG CORP | 100,000 | $10 | 0.0% | — | — | Put | 80706P953 |